Search

Your search keyword '"Yanaihara, Nozomu"' showing total 293 results

Search Constraints

Start Over You searched for: Author "Yanaihara, Nozomu" Remove constraint Author: "Yanaihara, Nozomu"
293 results on '"Yanaihara, Nozomu"'

Search Results

3. Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis

4. Personalized Treatment in Ovarian Cancer

6. Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G2/M phase in ovarian cancer.

12. EP169/#411 Machine learning method for differential diagnosis and prognosis prediction for early-stage uterine sarcoma using preoperative blood biomarker and age

13. EP260/#470 Effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese epithelial ovarian cancer: a single-center retrospective study

21. Supplemental Table S3. from Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers

22. Supplementary Data from Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype

23. Supplemental Figure S1. from Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers

24. Supplementary Data from MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival

29. CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data

30. CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data

31. Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway

33. Knowledge and practice for cervical cancer among female primary school teachers in Phnom Penh, Cambodia: A cross-sectional phone-based survey

35. Prevention and practice during the <scp>COVID</scp> ‐19 emergency declaration period in Japanese obstetrical/gynecological facilities

36. Survival Prognostic and Surrogate Values of the Early Modeled Ca-125 Kelim Score in First-Line Treatment of Ovarian Cancer: Results from The Gcig Individual Patient Data Meta-Analysis

38. Scoring Systems of Peritoneal Dissemination for the Prediction of Operative Completeness in Advanced Ovarian Cancer

41. A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk‐reducing surgery for hereditary breast and ovarian cancer

44. MicroRNA expression profiles associated with prognosis and therapeutic outcomes in colon adenocarcinoma

45. Assessment of progression-free survival as a surrogate end point of overall survival in first-line treatment of ovarian cancer

47. Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants

49. Interleukin-6 As An Enhancer of Anti-Angiogenic Therapy for Ovarian Clear Cell Carcinoma.

Catalog

Books, media, physical & digital resources